Yantai Dongcheng Pharmaceutical Group Co.,Ltd.
002675.SZ · SHZ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | CN¥1,045,039 | CN¥742,712 | CN¥697,377 | CN¥755,972 |
| Short-Term Investments | CN¥114,075 | CN¥200,694 | CN¥140,796 | CN¥148,542 |
| Receivables | CN¥1,009,422 | CN¥992,487 | CN¥969,926 | CN¥948,724 |
| Inventory | CN¥630,482 | CN¥629,389 | CN¥605,047 | CN¥646,221 |
| Other Curr. Assets | CN¥46,859 | CN¥50,305 | CN¥34,389 | CN¥41,029 |
| Total Curr. Assets | CN¥2,878,878 | CN¥2,647,359 | CN¥2,474,530 | CN¥2,567,649 |
| Property Plant & Equip (Net) | CN¥2,536,757 | CN¥2,491,251 | CN¥2,427,082 | CN¥2,334,898 |
| Goodwill | CN¥2,495,703 | CN¥2,498,974 | CN¥2,500,181 | CN¥2,500,810 |
| Intangibles | CN¥556,529 | CN¥546,126 | CN¥526,743 | CN¥518,230 |
| Long-Term Investments | CN¥411,354 | CN¥366,493 | CN¥212,069 | CN¥207,513 |
| Tax Assets | CN¥111,206 | CN¥108,586 | CN¥99,917 | CN¥94,889 |
| Other NC Assets | CN¥294,929 | CN¥296,725 | CN¥446,457 | CN¥410,689 |
| Total NC Assets | CN¥6,406,479 | CN¥6,308,155 | CN¥6,212,450 | CN¥6,067,029 |
| Other Assets | CN¥0 | CN¥0 | CN¥0 | CN¥0 |
| Total Assets | CN¥9,285,357 | CN¥8,955,514 | CN¥8,686,980 | CN¥8,634,678 |
| Liabilities | – | – | – | – |
| Payables | CN¥206,168 | CN¥621,726 | CN¥595,359 | CN¥588,407 |
| Short-Term Debt | CN¥777,668 | CN¥313,301 | CN¥288,123 | CN¥448,880 |
| Tax Payable | CN¥0 | CN¥90,451 | CN¥78,639 | CN¥70,018 |
| Deferred Revenue | CN¥131,486 | CN¥0 | CN¥0 | CN¥0 |
| Other Curr. Liab. | CN¥360,261 | CN¥220,383 | CN¥193,099 | CN¥199,814 |
| Total Curr. Liab. | CN¥1,686,474 | CN¥1,607,074 | CN¥1,542,348 | CN¥1,753,956 |
| LT Debt | CN¥347,811 | CN¥319,283 | CN¥317,138 | CN¥301,858 |
| Deferred Rev, NC | CN¥193,229 | CN¥197,390 | CN¥192,374 | CN¥195,685 |
| Deferred Tax Liab, NC | CN¥15,616 | CN¥16,830 | CN¥16,813 | CN¥17,406 |
| Other NC Liab. | CN¥1,439,661 | CN¥1,226,120 | CN¥1,096,241 | CN¥960,423 |
| Total NC Liab. | CN¥2,153,453 | CN¥1,893,070 | CN¥1,744,750 | CN¥1,509,254 |
| Other Liabilities | CN¥0 | CN¥0 | CN¥0 | CN¥0 |
| Cap. Leases | CN¥0 | CN¥133,447 | CN¥122,183 | CN¥33,883 |
| Total Liabilities | CN¥3,839,927 | CN¥3,500,145 | CN¥3,287,099 | CN¥3,263,210 |
| Equity | – | – | – | – |
| Pref Stock | CN¥0 | CN¥0 | CN¥0 | CN¥0 |
| Common Stock | CN¥824,596 | CN¥824,596 | CN¥824,596 | CN¥824,596 |
| Retained Earnings | CN¥1,487,885 | CN¥1,427,421 | CN¥1,388,238 | CN¥1,363,507 |
| AOCI | CN¥2,060,680 | CN¥293,758 | CN¥0 | CN¥294,086 |
| Other Equity | CN¥0 | CN¥0 | CN¥2,282,590 | CN¥0 |
| Total Equity | CN¥4,373,160 | CN¥4,487,630 | CN¥4,495,424 | CN¥4,480,445 |
| Supplemental Information | – | – | – | – |
| Minority Interest | CN¥1,072,270 | CN¥967,740 | CN¥904,456 | CN¥891,023 |
| Total Liab. & Tot. Equity | CN¥9,285,357 | CN¥8,955,514 | CN¥8,686,980 | CN¥8,634,678 |
| Net Debt | CN¥80,440 | -CN¥110,128 | -CN¥92,116 | -CN¥5,234 |